Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hitchin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nature|February 17, 2000
Quality of the fossil record through timeM J Benton, M A Wills, R Hitchin
Systematic Biology|June 18, 2002
Assessing congruence between cladistic and stratigraphic dataM J Benton, R Hitchin, M A Wills
Analytical Biochemistry|August 6, 2013
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1James T Lynch, Mark J Cockerill, James R Hitchin, et al.
Cancer Research|February 5, 2015
ERK5 is a critical mediator of inflammation-driven cancerKatherine G Finegan, Diana Perez-Madrigal, James R Hitchin, et al.
Journal of Cell Science|January 16, 2014
Torin1-mediated TOR kinase inhibition reduces Wee1 levels and advances mitotic commitment in fission yeast and HeLa cellsJane Atkin, Lenka Halova, Jennifer Ferguson, et al.
Journal of Medicinal Chemistry|March 31, 2022
NMR Molecular Replacement Provides New Insights into Binding Modes to Bromodomains of BRD4 and TRIM24Felix Torres, Reto Walser, Janina Kaderli, et al.
Cancer Cell|April 3, 2012
The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cellsWilliam J Harris, Xu Huang, James T Lynch, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2019
Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores - A cautionary disclosureBen Acton, Helen F Small, Kate M Smith, et al.
Journal of Medicinal Chemistry|April 18, 2012
Novel steroid inhibitors of glucose 6-phosphate dehydrogenaseNiall M Hamilton, Martin Dawson, Emma E Fairweather, et al.
ACS Chemical Biology|October 1, 2016
First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to OlaparibDominic I James, Kate M Smith, Allan M Jordan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature|February 17, 2000
Quality of the fossil record through timeM J Benton, M A Wills, R Hitchin
Systematic Biology|June 18, 2002
Assessing congruence between cladistic and stratigraphic dataM J Benton, R Hitchin, M A Wills
Analytical Biochemistry|August 6, 2013
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1James T Lynch, Mark J Cockerill, James R Hitchin, et al.
Cancer Research|February 5, 2015
ERK5 is a critical mediator of inflammation-driven cancerKatherine G Finegan, Diana Perez-Madrigal, James R Hitchin, et al.
Journal of Cell Science|January 16, 2014
Torin1-mediated TOR kinase inhibition reduces Wee1 levels and advances mitotic commitment in fission yeast and HeLa cellsJane Atkin, Lenka Halova, Jennifer Ferguson, et al.
Journal of Medicinal Chemistry|March 31, 2022
NMR Molecular Replacement Provides New Insights into Binding Modes to Bromodomains of BRD4 and TRIM24Felix Torres, Reto Walser, Janina Kaderli, et al.
Cancer Cell|April 3, 2012
The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cellsWilliam J Harris, Xu Huang, James T Lynch, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2019
Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores - A cautionary disclosureBen Acton, Helen F Small, Kate M Smith, et al.
Journal of Medicinal Chemistry|April 18, 2012
Novel steroid inhibitors of glucose 6-phosphate dehydrogenaseNiall M Hamilton, Martin Dawson, Emma E Fairweather, et al.
ACS Chemical Biology|October 1, 2016
First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to OlaparibDominic I James, Kate M Smith, Allan M Jordan, et al.
Pageof 2